NOT-DA-19-045: Notice to Extend the Expiration Date of PAR-18-084 "Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)"

Notice to Extend the Expiration Date of PAR-18-084 "Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)"

Notice Number: NOT-DA-19-045

Key Dates
Release Date: May 22, 2019

Related Announcements
PAR-18-084

Issued by
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-084 "Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)"will be extended by one receipt cycle. The FOA now expires on January 8, 2020. NIDA does plan to reissue this FOA.

The FOA has been modified as follows:

Key Dates:

Currently reads:

Expiration Date September 8, 2019

Modified to read:

Expiration Date January 8, 2020

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Shelley Su, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-3869
Email:shelley.su@nih.gov